2008
1. F. Hoffmann-La Roche Ltd,
Switzerland.
2. OSI Pharmaceuticals, Inc.,
New York. ..... Plaintiffs
Through Dr.C.S.Vaidyanathan, Sr.Advocate with
Mr.Pravin ... plaintiffs, namely, F. Hoffmann-La Roche Ltd. and OSI
Pharmaceuticals Inc., have filed the suit for permanent injunction restraining
infringement of patent, rendition of accounts
Merck Sharp & Dohme Corporation & Anr. vs Glenmark Pharmaceuticals Ltd. on 7 October, 2015
Author: A.K. Pathak
Bench: A.K. Pathak ... Patro, Ms. Nupur Maithani
and Mr. Devender Rawat, Advs.
Versus
GLENMARK PHARMACEUTICALS LTD. ..... Defendant
Through Mrs. Pratibha M Singh, Sr. Adv. with
Ms. Saya Choudhary
year 1989 as a result of a
merger between two pharmaceutical companies namely, Bristol-
Myers Company founded in 1887 by William McLaren Bristol and
John ... 2013 Page 2 of 86
of plaintiff No.1 and markets pharmaceutical products in the
domestic market.
iii) Plaintiff No.1 along with its subsidiaries
Siddhant
Chamola, Ms. Devyani Nath and Mr.
Souradeep Mukhopadhyay, Advocates.
versus
INTAS PHARMACEUTICALS LIMITED .....Defendant
Through : Mr. C.S. Vaidyanathan, Senior Advocate
with Ms. Bitika ... India". The defendant in CS
(COMM) 410/2020 i.e. Intas Pharmaceuticals Limited will be referred to as
"Intas"; while the defendant
Eltrombopag
"is a compound which is disclosed and claimed, along with
pharmaceutically acceptable salts, hydrates, solvates and esters
thereof, as being useful ... compound as claimed in claim 1 as and when used
as a pharmaceutical composition along with the
pharmaceutically acceptable carrier or diluents of the kind
Bristol-Myers Squibb Holdings Ireland ... vs Bdr Pharmaceuticals International ... on 30 January, 2020
Author: Mukta Gupta
Bench: Mukta Gupta
* IN THE HIGH COURT OF DELHI ... Ridhie Bajaj,
Mr. Devinder Rawat, Ms. M. Dubey,
Advs.
versus
BDR PHARMACEUTICALS INTERNATIONAL PVT. LTD. &
ANR. ..... Defendant
Represented by: Mr. J. Sai Deepak
parent claim is as under:
a multilayer, thermoformable, translucent food and pharmaceutical packaging film consisting of a core layer of 100-1000 microns thickness ... said core layer and at least 0-250 microns thick food and pharmaceutical grade polymeric layer provided at least on one side of the core
infringes the plaintiffs‟
patent No. 215528 including Lorcaserin or any of its pharmaceutically
acceptable salts including Lorcaserin Hydrochloride (hereinafter referred to
as „LH‟) and Lorcaserin ... order dated 14th February, 2017 in Bayer Intellectual Property
GMBH v. BDR Pharmaceuticals International Pvt. Ltd .
9. Since the defendants have not yet launched their
Astrazeneca Ab & Anr. vs Emcure Pharmaceuticals Limited on 15 January, 2020
Equivalent citations: AIRONLINE 2020 DEL 607
Author: Mukta Gupta
Bench: Mukta Gupta ... Vaishali
Mittal, Mr. Siddhant Chamola, Ms.
Ankita Sabharwal, Advs.
versus
EMCURE PHARMACEUTICALS LIMITED ..... Defendant
Represented by: Mr. J. Sai Deepak, Mr. G. Natraj, Mr.
Abhishek
Boehringer Ingelheim Pharma vs Vee Excel Drugs And Pharmaceuticals ... on 2 June, 2022
Author: Ajay Mohan Goel
Bench: Ajay Mohan Goel
IN THE HIGH COURT ... WHITEFIELDS, KONDAPUR,
HYDERABAD 500084 TELANGANA.
2) EMCURE PHARMACEUTICALS
LIMITED SHOP NO. 15, 2ND FLOOR, CO.
DUTTA MARKETINGS, SANJAULI,
SHIMLA, THROUGH ITS MANAGING
DIRECTOR.
::: Downloaded
